BBIO
Price
$26.49
Change
+$0.28 (+1.07%)
Updated
Dec 20 closing price
59 days until earnings call
LIXT
Price
$1.98
Change
+$0.07 (+3.66%)
Updated
Dec 20 closing price
Ad is loading...

BBIO vs LIXT

Header iconBBIO vs LIXT Comparison
Open Charts BBIO vs LIXTBanner chart's image
BridgeBio Pharma
Price$26.49
Change+$0.28 (+1.07%)
Volume$4.2M
CapitalizationN/A
Lixte Biotechnology Holdings
Price$1.98
Change+$0.07 (+3.66%)
Volume$7.19K
CapitalizationN/A
BBIO vs LIXT Comparison Chart
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBIO vs. LIXT commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a Hold and LIXT is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BBIO: $26.49 vs. LIXT: $1.98)
Brand notoriety: BBIO and LIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 200% vs. LIXT: 1%
Market capitalization -- BBIO: $5.01B vs. LIXT: $4.45M
BBIO [@Biotechnology] is valued at $5.01B. LIXT’s [@Biotechnology] market capitalization is $4.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileLIXT’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • LIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, BBIO is a better buy in the long-term than LIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 6 TA indicator(s) are bullish while LIXT’s TA Score has 6 bullish TA indicator(s).

  • BBIO’s TA Score: 6 bullish, 4 bearish.
  • LIXT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BBIO and LIXT are a good buy in the short-term.

Price Growth

BBIO (@Biotechnology) experienced а -3.64% price change this week, while LIXT (@Biotechnology) price change was -0.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BBIO is expected to report earnings on Feb 20, 2025.

LIXT is expected to report earnings on May 10, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($5.01B) has a higher market cap than LIXT($4.45M). LIXT YTD gains are higher at: -15.745 vs. BBIO (-34.382). LIXT has higher annual earnings (EBITDA): -3.98M vs. BBIO (-350.26M). BBIO has more cash in the bank: 266M vs. LIXT (1.64M). LIXT has less debt than BBIO: LIXT (100K) vs BBIO (1.73B). BBIO has higher revenues than LIXT: BBIO (218M) vs LIXT (0).
BBIOLIXTBBIO / LIXT
Capitalization5.01B4.45M112,416%
EBITDA-350.26M-3.98M8,805%
Gain YTD-34.382-15.745218%
P/E RatioN/AN/A-
Revenue218M0-
Total Cash266M1.64M16,239%
Total Debt1.73B100K1,730,000%
FUNDAMENTALS RATINGS
LIXT: Fundamental Ratings
LIXT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOLIXT
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
76%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 4 days ago
71%
View a ticker or compare two or three
Ad is loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFIE1.160.06
+5.45%
Faraday Future Intelligent Electric Inc
TPR64.151.49
+2.38%
Tapestry
CION11.650.06
+0.52%
CION Investment Corp
ARWR19.45-0.05
-0.26%
Arrowhead Pharmaceuticals
SKYX1.03-0.02
-1.90%
SKYX Platforms Corp

LIXT and

Correlation & Price change

A.I.dvisor tells us that LIXT and IBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIXT and IBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
+3.66%
IBIO - LIXT
30%
Poorly correlated
+2.48%
NTLA - LIXT
28%
Poorly correlated
+0.83%
INCY - LIXT
28%
Poorly correlated
+2.65%
BBIO - LIXT
27%
Poorly correlated
+1.07%
PMN - LIXT
26%
Poorly correlated
+1.88%
More